Yayınlar & Eserler

Yayın Ağı
Makaleler 25
Tümü (25)
SCI-E, SSCI, AHCI (13)
SCI-E, SSCI, AHCI, ESCI (15)
ESCI (2)
Scopus (19)
TRDizin (5)
Diğer Yayınlar (3)

1. Determination of the Physicochemical Properties of Piroxicam

ÇELEBİER M., NENNİ M., KAPLAN O., Akgeyik E., Kaynak M. S., ŞAHİN S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.17, sa.5, ss.535-541, 2020 (ESCI) identifier identifier identifier

2. Demographics and clinical characteristic of patients diagnosed with hen’s egg allergy

TOPAL E., ARGA M., Celiksoy M. H., Kaynak M. S., DUMAN Y., DEMİRTAŞ M. S., et al.
Annals of Medical Research , cilt.26, sa.1, ss.1-4, 2019 (Hakemli Dergi)

3. Independent predictive factors for the persistence and tolerance of cow's milk allergy

TOPAL E., Celiksoy M. H., ARGA M., KAYNAK M. S., DUMAN Y., DEMIRTAS S., et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY , cilt.9, sa.1, ss.67-71, 2019 (SCI-Expanded) identifier identifier identifier

4. Demographics and clinical characteristic of patients diagnosed with hen’s egg allergy

TOPAL E., arga m., çeliksoy m. h., KAYNAK M. S., DUMAN Y., DEMİRTAŞ M. S., et al.
Annals of Medical Research , cilt.26, sa.1, ss.1-4, 2018 (Hakemli Dergi)

5. Comparison of intestinal permeability of nebivolol hydrochloride loaded solid lipid nanoparticles with commercial nebivolol tablet

GÖKÇE E. H., KAYNAK M. S., YURDASİPER ERDEM A., Ustundag-Okur N., ŞAHİN S.
JOURNAL OF RESEARCH IN PHARMACY , cilt.22, sa.4, ss.578-586, 2018 (ESCI) identifier identifier

6. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression

Gulsun T., Ozturk N., Kaynak M. S., Vural I., Sahin S.
PHARMAZIE , cilt.72, sa.7, ss.389-394, 2017 (SCI-Expanded) identifier identifier identifier

7. Development of HPLC Methods for Individual Determination of 20 Active Pharmaceutical Ingredients for Ussing-Chamber Studies

KAYNAK M. S., Akgeyik E., ATEŞ M., ÇELEBİER M., ŞAHİN S.
CURRENT PHARMACEUTICAL ANALYSIS , cilt.13, sa.2, ss.145-153, 2017 (SCI-Expanded) identifier identifier

8. Application of HPLC to Investigate the Physicochemical Properties and Intestinal Permeability of Ketoprofen

KAYNAK M. S., ÇELEBİER M., Akgeyik E., ŞAHİN S., Altinoz S.
CURRENT PHARMACEUTICAL ANALYSIS , cilt.13, sa.1, ss.72-79, 2017 (SCI-Expanded) identifier identifier

9. Effect of permeability enhancers on paracellular permeability of acyclovir

Ates M., KAYNAK M. S., ŞAHİN S.
JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.68, sa.6, ss.781-790, 2016 (SCI-Expanded) identifier identifier identifier

10. Evaluation of Pharmaceutical Quality of Conventional Dosage Forms Containing Paracetamol and Caffeine Available in the Turkish Drug Market

Akgeyik E., KAYNAK M. S., ÇELEBİER M., Altinoz S., ŞAHİN S.
DISSOLUTION TECHNOLOGIES , cilt.23, sa.2, ss.36-41, 2016 (SCI-Expanded) identifier identifier

11. Comparison of Dissolution Profiles of Commercially Available Lamivudine Tablets

ÖZTÜRK N., KAYNAK M. S., ŞAHİN S.
DISSOLUTION TECHNOLOGIES , cilt.22, sa.4, ss.38-43, 2015 (SCI-Expanded) identifier identifier

12. SIMULTANEOUS DETERMINATION OF ACYCLOVIR METOPROLOL AND PHENOL RED BY A RP HPLC METHOD FOR INTESTINAL PERFUSION STUDIES

ATEŞ M., KAYNAK M. S., ŞAHİN S.
Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi , cilt.35, sa.2, ss.146-161, 2015 (Hakemli Dergi)

13. Determination of Regional Intestinal Permeability of Diclofenac and Metoprolol Using a Newly-Developed and Validated High Performance Liquid Chromatographic Method

BÜYÜKTUNCEL S. E., KAYNAK M. S., Şahin S., ÇAĞLAR YILMAZ H.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH , cilt.14, sa.1, ss.163-170, 2015 (SCI-Expanded)

14. Determination of Regional Intestinal Permeability of Diclofenac and Metoprolol Using a Newly-Developed and Validated High Performance Liquid Chromatographic Method

Kaynak M. S., BUYUKTUNCEL E., Caglar H., ŞAHİN S.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH , cilt.14, sa.1, ss.163-170, 2015 (SCI-Expanded) identifier identifier

15. UV Spectrophotometric Method for Determination of the Dissolution Profile of Rivaroxaban

ÇELEBİER M., KAYNAK M. S., Altinoz S., ŞAHİN S.
DISSOLUTION TECHNOLOGIES , cilt.21, sa.4, ss.56-59, 2014 (SCI-Expanded) identifier identifier

16. Development and validation of a RP HPLC method for determination of solubility of furosemide

KAYNAK M. S., ŞAHİN S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.10, sa.1, ss.25-34, 2013 (Scopus)

17. Determination of Amlodipine and Furosemide with newly developed and validated RP HPLC method in commercially available tablet dosage forms

ŞİMŞEK F. Ö., KAYNAK M. S., ŞANLI N., ŞAHİN S.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.32, sa.2, ss.145-158, 2012 (Hakemli Dergi)

18. Development of a HPLC Method for the Determination of Cyclosporine A From Chitosan Nanoparticles

Buyuktuncel E., Yucel C., KAYNAK M. S., AKTAŞ Y.
LATIN AMERICAN JOURNAL OF PHARMACY , cilt.31, sa.8, ss.1083-1088, 2012 (SCI-Expanded) identifier identifier

19. Bioavailability file Amlodipin

KAYNAK M. S., BOGACZ A., MICHAL S., ŞAHİN S.
FABAD Journal of Pharmaceutical Sciences , cilt.36, sa.4, ss.207-222, 2011 (Scopus)

20. HPLC method development for the simultaneous analysis of amlodipine and valsartan in combined dosage forms and in vitro dissolution studies

ÇELEBİER M., KAYNAK M. O., Altinoz S., ŞAHİN S.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.46, sa.4, ss.761-768, 2010 (SCI-Expanded) identifier identifier

21. HPLC METHOD DEVELOPMENT AND VALIDATION: SIMULTANEOUS DETERMINATION OF DICLOFENAC, METOPROLOL AND PHENOL RED IN BIOLOGICAL MATRIX FOR INTESTINAL PERFUSION STUDIES

Caglar H., KAYNAK M. S., ŞAHİN S., Buyuktuncel E.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.179-181, 2009 (SCI-Expanded) identifier

22. A New HPLC approach for determination of in vitro solubility of naproxen sodium

KAYNAK M. S., ŞAHİN S.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.28, sa.1, ss.49-62, 2008 (Scopus)

23. Validated HPLC method development The simultaneous analysis of amlodipine and valsartan in samples for liver perfusion studies

ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.28, sa.1, ss.15-30, 2008 (Scopus)

24. Formulation of controlled release glipizide pellets using pan coating method

KAYNAK M. S., KAŞ H. S., ÖNER L.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.27, sa.2, ss.93-106, 2007 (Hakemli Dergi)

25. Bioavailability file Glipizide

KAYNAK M. S., ÖNER L.
FABAD Journal of Pharmaceutical Sciences , cilt.31, sa.3, ss.151-161, 2006 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 56

1. İnek sütü proteini alerjisinin devamlılığını ve toleransını öngören faktörler

TOPAL E., ÇELİKSOY M. H., ARGA M., KAYNAK M. S., DUMAN Y., DEMİRTAŞ M. S., et al.
16.Anadolu Gastroenteroloji Günleri, Şanlıurfa, Türkiye, 11 Eylül 2020, ss.123, (Tam Metin Bildiri)

2. Comparison of intestinal permeability of nebivolol hydrochloride in solid lipid nanoparticles and commercial tablet GPSS

GÖKÇE E. H., KAYNAK M. S., YURDASİPER A., ÜSTÜNDAĞ OKUR N., ŞAHİN S.
2nd Gazi Pharma Symposium (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

3. SYNTHESIS AND CHARACTERIZATION OF SILICA NANOPARTICLES: OBTAINING NANOPARTICLES SMALLER THAN 100 NM

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., KAYNAK M. S., AKTAŞ Y., et al.
2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

4. Comparison of HPLC and Spectrophotometric Methods on Determination of the pKa of Drugs

ÇELEBİER M., NENNİ M., kaplan o., akgeyik e., KAYNAK M. S., ALTINÖZ S., et al.
Symposium on Drug Research Development, 5 - 07 Ekim 2017, (Özet Bildiri)

5. Transferrine hedeflendirilmiş paklitaksel yüklü PLGA nanopartiküllerinin meme kanserindeki etkinliği

TONBUL H., ŞAHİN A., ÖZTÜRK N., VURAL İ., KAYNAK M. S., ÇAPAN Y.
1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 Haziran - 02 Ocak 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Development and Evaluation of Terbutaline Sulfate Containing Orally Disintegrating Tablets

İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., KAYNAK M. S., ÖNER L., ŞAHİN S.
AAPS 2016, 13 - 17 Kasım 2016, (Özet Bildiri)

7. Determination of pKa Value of Anticonvulsant Nafimidone Oxime O Propyl Ether

Akgeyik E., ÖZDEMİR Z., ATEŞ M., KAYNAK M. S., ÇELEBİER M., ALTINÖZ S., et al.
AAPS 2016, 13 - 17 Kasım 2016, (Özet Bildiri)

8. DETERMINATION OF pKa VALUES OF ANTICONVULSANT NAFIMIDONE OXIME O PROPYL ETHER

AKGEYİK E., ÖZDEMİR Z., ATEŞ M., KAYNAK M. S., ÇELEBİER M., ALTINÖZ S., et al.
2016 AAPS Annual Meeting and Exposition, Denver, Amerika Birleşik Devletleri, 13 - 17 Kasım 2016, (Özet Bildiri)

9. Determination of Regional Intestinal Permeability of Valgancyclovir and Metoprolol Using a Newly Developed and Validated High Performance Liquid Chromatographic Method

ŞANLI S., ŞANLI N., KAYNAK M. S.
10th Aegean Analytical Chemsitry Days, 29 Eylül - 02 Ekim 2016, (Özet Bildiri)

10. Investigation of the stability of prednisolone powder for injection after reconstitution

ÇELEBİER M., KAYNAK M. S., NENNİ M., ALTINÖZ S., ŞAHİN S.
IPTS 2016, 18 - 21 Eylül 2016, (Tam Metin Bildiri)

11. Development of Metformin Hydrochloride and Glyburide Containing Orally Disintegrating Tablets

GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., KAYNAK M. S., ÖNER L., ŞAHİN S.
AAPS 2015, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, 25 - 29 Ekim 2015

12. Quality Control of Extended Release Metoprolol Tartrate Tablets Available in Turkish Drug Market

GENÇER A., AKGEYİK E., KAYNAK M. S., ÇELEBİER M., ŞAHİN S.
MAGUM-DRD 2015, International Symposium on Drug Research and Development From Chemistry to Medicine, Eskişehir, Türkiye, 15 - 17 Ekim 2015

13. Development of HPLC Methods for Individual Determination of 20 Active Pharmaceutical Ingredients for Ussing Chamber Studies

KAYNAK M. S., AKGEYİK E., ATEŞ M., ÇELEBİER M., ŞAHİN S.
MAGUM-DRD 2015, International Symposium on Drug Research and Development From Chemistry to Medicine, Eskişehir, Türkiye, 15 - 17 Ekim 2015

14. Assesment of Pharmaceutical Quality of Furosemide Tablets Available in Turkish Drug Market

YILDIZ B., AKGEYİK E., KAYNAK M. S., ÇELEBİER M., ŞAHİN S.
MAGUM-DRD 2015, International Symposium on Drug Research and Development From Chemistry to Medicine, Eskişehir, Türkiye, 15 - 17 Ekim 2015

15. Determination of Physicochemical Properties of Piroxicam

ÇELEBİER M., NENNİ M., KAPLAN O., AKGEYİK E., KAYNAK M. S., ALTINÖZ S., et al.
MAGUM-DRD 2015, International Symposium on Drug Research and Development From Chemistry to Medicine, Eskişehir, Türkiye, 15 - 17 Ekim 2015

16. HPLC Method Development for Analysis of Furosemide in Quality Control Laboratories

YILDIZ B., AKGEYİK E., KAYNAK M. S., ÇELEBİER M., ŞAHİN S.
Kromatografi 2015 UŞAK, Uşak, Türkiye, 8 - 10 Nisan 2015

17. HPLC Method Development and Validation for Simultaneous Determination of Ketoprofen Metoprolol and Phenol Red

Akgeyik E., ATEŞ M., KAYNAK M. S., ÇELEBİER M., ŞAHİN S., ALTINÖZ S.
AAPS Annual Meeting 2014, 2 - 06 Kasım 2014, (Özet Bildiri)

18. Investigation of Physicochemical Properties of Ketoprofen by HPLC

ÇELEBİER M., Akgeyik E., ATEŞ M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
AAPS Annual Meeting 2014, 2 - 06 Kasım 2014, (Özet Bildiri)

19. Investigation of Permeability Enhancers on Paracellular Permeability

ATEŞ M., KAYNAK M. S., ŞAHİN S.
AAPS Annual Meeting 2014, 2 - 06 Kasım 2014, (Özet Bildiri)

20. Investigation of Curcumin Effect on the Intestinal Breast Cancer Resistance Protein

GÜDER F., KAYNAK M. S., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014 Sürdürülebilir Kalkınma

21. Potential Effect of Capsaicin on Intestinal Breast Cancer Resistance Protein

ŞENER E., KAYNAK M. S., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014 Sürdürülebilir Kalkınma

22. Investigation of Dose Effect on the Segmental Intestinal Permeability of Amlodipine

KAYNAK M. S., BOGACZ A., STELMASINSKI M., ATEŞ M., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014

23. Investigation of pH Effect on the Intestinal Permeability of Ketoprofen by HPLC A Basic Approach to correlate the in vitro and in situ Results

KAYNAK M. S., ÇELEBİER M., Akgeyik E., ATEŞ M., ŞAHİN S., ALTINÖZ S.
ISC 2014, 30th International Symposium on Chromatography (Communicating Separation Science for the Future), 14 - 18 Eylül 2014, (Özet Bildiri)

24. Quality Control of Conventional Paracetamol and Caffeine Combined Dosage Forms in Turkish Drug Market

AKGEYİK E., ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
17th International Pharmaceutical Technology Symposium. (IPTS 2014), Antalya, Türkiye, 8 - 10 Eylül 2014, (Tam Metin Bildiri)

25. Simultaneous Determination of Acyclovir Metoprolol and Phenol Red in Biological Matrix for Intestinal Perfusion Studies

ATEŞ M., KAYNAK M. S., ŞAHİN S.
17th International Pharmaceutical Technology Symposium. (IPTS 2014), 8 - 10 Eylül 2014, (Özet Bildiri)

26. Lamivudin in İntestinal Permeabilitesini Ters Faz Sıvı Kromatografik Yöntem ile Tayini

ŞANLI S., KAYNAK M. S., ERTÜRK E., GÜLPEMBE H., ŞANLI N.
7. Ulusal Analitik Kimya Kongresi, Kahramanmaraş, Türkiye, 1 - 05 Eylül 2014, (Özet Bildiri)

27. Oseltamivir Fosfat ın İntestinal Permeabilitesini Ters Faz Sıvı Kromatografik Yöntem ile Tayini

ERTÜRK E., KAYNAK M. S., ŞANLI S., HALAY G., ŞANLI N.
7. Ulusal Analitik Kimya Kongresi, Kahramanmaraş, Türkiye, 1 - 05 Eylül 2014, (Özet Bildiri)

28. Effect of Capsaicin on Intestinal P glycoprotein

ŞENER E., KAYNAK M. S., ŞAHİN S.
AAPS 2012, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Şikago, Amerika Birleşik Devletleri, 14 - 17 Ekim 2012

29. Investigation of Curcumin Effect on Intestinal P glycoprotein

GÜDER F., KAYNAK M. S., ŞAHİN S.
AAPS 2012, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Şikago, Amerika Birleşik Devletleri, 14 - 17 Ekim 2012

30. HPLC Method Development for Determination and In Vitro Dissolution Studies for Rivaroxaban

ÇELEBİER M., KOÇAK E., SÜSLÜ İ., KAYNAK M. S., ALTINÖZ S.
9th Central European Symposium on Pharmaceutical Technology, Dubrovnik, Hırvatistan, 20 - 22 Eylül 2012

31. Comparision of Dissolution Profiles of Two Commercially Available Furosemide Tablets

ÖZTÜRK N., ATEŞ M., KAYNAK M. S., ŞAHİN S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development From Chemistry to Medicine, 27 - 29 Mayıs 2011, (Özet Bildiri)

32. Determination of Permeability of Diclofenac Sodium in the In Situ Intestinal Perfusion Preparation

KAYNAK M. S., ÇAĞLAR H., BÜYÜKTUNCEL S. E., ŞAHİN S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development From Chemistry to Medicine, Antalya, Türkiye, 27 - 29 Mayıs 2011

33. Development and Validation of a RP HPLC Method for Determination of Furosemide in Tablet Dosage Forms

ŞİMŞEK F., ERDOĞDU S., KAYNAK M. S., ŞANLI N., ŞAHİN S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development From Chemistry to Medicine, Antalya, Türkiye, 27 - 29 Mayıs 2011

34. Development of RP HPLC Method for the Determination of Amlodipine in Commercially Available Tablet Dosage Forms

FEVZİYE Ş., DİRİCAN K. Z., KAYNAK M. S., ŞANLI N., ŞAHİN S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development from Chemistry to Medicine, Antalya, Türkiye, 27 - 29 Mayıs 2011

35. Hepatic Disposition of Naproxen Sodium in Cirrhotic Rat Liver

KAYNAK M. S., ŞAHİN S.
PSWC-AAPS 2010, Pharmaceutical Sciences World Congress-American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, New Orleans, Amerika Birleşik Devletleri, 14 - 18 Kasım 2010

36. Determination of In Vitro Dissolution Profiles of Amlodipine Besylate and Olmesartan Medoxomil Using a Newly Developed HPLC Method

KAYNAK M. S., ÇELEBİER M., ŞAHİN S., ALTINÖZ S.
PSWC-AAPS 2010, Pharmaceutical Sciences World Congress- American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, New Orleans, Amerika Birleşik Devletleri, 14 - 18 Kasım 2010

37. Determination of time to reach steady state in different intestinal segments using phenol red

ŞENER E., KAYNAK M. S., ŞAHİN S.
PSWC-AAPS 2010, Pharmaceutical Sciences World Congress-American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, New Orleans, Amerika Birleşik Devletleri, 14 - 18 Kasım 2010

38. Estimation of Distributional Spaces in the Dual Perfused Cirrhotic Rat Liver

KAYNAK M. S., ŞAHİN S.
AAPS 2009, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Los-Angeles, Şili, 8 - 12 Kasım 2009

39. Investigation of Hepatic Disposition of Furosemide in the Dual Perfused Cirrhotic Rat Liver

KAYNAK M. S., ŞAHİN S.
AAPS 2009, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Los-Angeles, Şili, 8 - 12 Kasım 2009

40. Method Development and Validation Simultaneous Determination of Diclofenac Metoprolol and Phenol Red in Biological Matrix for Intestinal Perfusion Studies

ÇAĞLAR H., KAYNAK M. S., ŞAHİN S., BÜYÜKTUNCEL S. E.
3rd BBBBosphorus International Conference on Pharmaceutical Sciences, Antalya, Türkiye, 26 - 28 Ekim 2009

41. Development and Validation of a New HPLC Method with Fluorometric Detection for Analysis of Furosemide in Samples for Liver Perfusion Studies

KAYNAK M. S., ŞAHİN S.
69th International Congress of FIP, İstanbul, Türkiye, 3 - 08 Eylül 2009

42. HPLC Determination of Olmesatran Medoxomil and Amlodipine Besylate in Tablets

ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
5th Conference on Separation and Related Techniques by Nordic Separation Sciences Society (NoSSS2009), Talin, Ermenistan, 26 - 29 Ağustos 2009

43. Determination of Naproxen Sodium in Samples for Liver Perfusion Studies via Newly Developed HPLC Method with Fluorometric Detection

KAYNAK M. S., ŞAHİN S.
ISOPS 2009, 9th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 23 - 06 Haziran 2009

44. Determination of the In Vitro Dissolution profiles of Amlodipine and Valsartan Combined Tablet Dosage Forms by HPLC

KAYNAK M. S., ÇELEBİER M., ŞAHİN S., ALTINÖZ S.
MAGUM-DRD 2009, International Symposium on Drug Research and Development From Chemistry to Medicine, İstanbul, Türkiye, 4 - 07 Mayıs 2009

45. Determination of Tissue Water Contents of Cirrhotic Rats

KAYNAK M. S., YILDIZ I., ŞAHİN S.
AAPS 2008, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Atlanta, Amerika Birleşik Devletleri, 16 - 20 Kasım 2008

46. Investigation of Intestinal Permeability of Naproxen Sodium and Furosemide in cirrhotic rats

KAYNAK M. S., YILDIZ I., ŞAHİN S.
AAPS 2008, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Atlanta, Amerika Birleşik Devletleri, 16 - 20 Kasım 2008

47. Simultaneous Determination of Amlodipine Besylate and Valsartan in Tablets by HPLC

ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
6th Aegean Analytical Chemistry Days, Denizli, Türkiye, 9 - 12 Ekim 2008

48. HPLC Method Development for the Simultaneous Analysis of Amlodipine Besylate and Valsartan in Samples for Liver Perfusion Studies

ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
XX Congress of Chemist and Technologists of Macedonia with V Congress of Metallurgists of Macedonia, Ohrid, Makedonya, 17 Eylül - 20 Ağustos 2008

49. Determination of Specific Hepatic Arterial Space in Cirrhotic Rats

KAYNAK M. S., ŞAHİN S.
14th International Pharmaceutical Technology Symposium (IPTS 2008), Antalya, Türkiye, 6 - 10 Eylül 2008, (Tam Metin Bildiri)

50. Investigation of Solubility and Permeability Characteristics of Furosemide

KAYNAK M. S., ŞAHİN S., HINCAL A.
3rd World Congress of Board of Pharmaceutical Sciences of FIP (PSWC), Amsterdam, Hollanda, 22 - 25 Nisan 2007

51. Determination of solubility and intestinal permeability Naproxen Sodium

KAYNAK M. S., ŞAHİN S., HINCAL A.
Pre-Satellite Meeting for and by Ph.D. Students and Postdoctoral Fellows of the 3rd World Congress of Board of Pharmaceutical Sciences of FIP (PSWC), Amsterdam, Hollanda, 20 - 21 Nisan 2007

52. Hepatic Disposition of Trimethoprim and Sulfamethoxazole

ŞAHİN S., SAYAR E., KAYNAK M. S., HINCAL A.
13th International Pharmaceutical Technology Symposium IPTS 2006, 10 - 13 Eylül 2006, (Tam Metin Bildiri)

53. Potential Use of Freeze Drying Technique for Determining of Tissue Water

ŞAHİN S., KARABEY Y., KAYNAK M. S., ATİLLA H.
1st BBBB Conference on Pharmaceutical Sciences, Siofok, Macaristan, 26 - 28 Eylül 2005

54. Estimation of Distributional Volumes in The Perfused Rat Liver

KARABEY Y., KAYNAK M. S., ŞAHİN S., ÖNER L., HINCAL A.
8th European Congress of Pharmaceutical Science, EUFEPS 2004, Brüksel, Belçika, 17 - 20 Ekim 2004, cilt.23, ss.71

55. A Comparative Study on Controlled Release Hydrophilic Matrix Tablets Containing Glipizide

KAYNAK M. S., KAŞ S., ÖNER L.
11th International Pharmaceutical Technology Symposium (IPTS 2002), İstanbul, Türkiye, 9 - 11 Eylül 2002, (Tam Metin Bildiri)

56. Formulation of controlled release glipizide pellets using pan coating method

KAYNAK M. S., KAŞ H. S., ÖNER L.
10th International Pharmaceutical Technology Symposium. (IPTS 2000), İstanbul, Türkiye, 11 - 13 Eylül 2000, (Tam Metin Bildiri)
Kitaplar 1

1. Türk Farmakopesi II 2016

ÖZKAN Y., SALTAN H. G., SARAÇ TARHAN S., AYDIN A., ÖZKAN S. A., SÜZEN H. S., et al.
TC Sağlık Bakanlığı, 2016
Metrikler

Yayın

83

Yayın (WoS)

15

Yayın (Scopus)

19

Atıf (WoS)

43

H-İndeks (WoS)

4

Atıf (Scopus)

53

H-İndeks (Scopus)

5

Proje

4

Tez Danışmanlığı

1
BM Sürdürülebilir Kalkınma Amaçları